Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostatic Artery Embolization vs. Pharmacotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: a Multicenter Randomized Controlled Trial

NCT04245566 is registered in ClinicalTrials.gov with Dominik Abt as lead sponsor.

NCT NCT04245566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04245566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostatic Artery Embolization vs. Pharmacotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: a Multicenter Randomized Controlled Trial
Lead sponsor
Dominik Abt
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2021
Completion date
December 31, 2025
Enrollment
425 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, minimally invasive treatment, pharmacotherapy, prostatic artery embolization